Clinical trial
Induction Treatment Followed by Immunosuppression Withdrawal in Liver…
NCT00436722 · Hospital Clinic of Barcelona, Other · Terminated
Key facts
| NCT number | NCT00436722 |
|---|---|
| Title | Induction Treatment Followed by Immunosuppression Withdrawal in Liver Transplantation: A Comparative Trial |
| Official title | Study of ATEGE-Fresenius Induction in Liver Transplantation Followed by Tacrolimus Weaning. |
| Acronym | ATEGE-LIVER |
| Lead sponsor | Hospital Clinic of Barcelona, Other |
| Collaborators | Fresenius AG Industry Astellas Pharma Inc |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Liver Diseases |
| Intervention type | Drug |
| Interventions | ATG (Fresenius Biotech) |
| Enrollment | 72 |
| Start date | Jun 1, 2006 |
| Primary completion | Jul 1, 2009 |
| First posted | Feb 19, 2007 |
| Last update posted | May 20, 2009 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: